pharmaceuticals
pharmaceuticals Articles
Trevena charged after the FDA granted a Breakthrough Therapy designation to its lead product candidate for the management of acute pain.
Published:
Last Updated:
Allergan reported better-than-expected fourth-quarter financial results before the markets opened on Monday.
Published:
Last Updated:
Over the past week, Zafgen and a few other biotech companies made impressive runs. These moves were the result of positive trial results and an FDA meeting.
Published:
Last Updated:
AstraZeneca has announced that the European Commission granted marketing authorization for two of its treatments: Zurampic for gout and Brilique for heart attack patients.
Published:
Last Updated:
Aerie Pharmaceuticals was one of the more bullish health care stocks on Thursday morning, following the release of its interim safety results.
Published:
Last Updated:
Regulus Therapeutics has reported positive interim results from its Phase 2 study for the treatment of hepatitis C virus (HCV) infection.
Published:
Last Updated:
Ocular Therapeutix led the bulls in early trading indications on Thursday, following a positive meeting with the FDA.
Published:
Last Updated:
In 2016 alone, this stock has taken a beating, and unless this company can turn itself around in the near future, it could be the end.
Published:
Last Updated:
Spring Bank Pharmaceuticals has amended it filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
This clinical-stage biopharmaceutical company focused on complex biosimilar therapeutics has filed for an IPO.
Published:
Last Updated:
Baxalta is scheduled to report fourth-quarter and full-year results before markets open on Tuesday.
Published:
Last Updated:
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
Published:
Last Updated:
These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of last week.
Published:
Last Updated:
Hutchinson China MediTech has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Syndax Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated: